Detection of differentially expressed genes in human bladder cancer cells using arbitrarily primed PCR of RNA

S Maack1, R Knuechel, F Hofstaedter

  • 1UNIV MARBURG,MED CTR,DEPT NEUROPATHOL,D-35043 MARBURG,GERMANY. UNIV REGENSBURG,INST PATHOL,D-93053 REGENSBURG,GERMANY.

Insights

This study identified differentially expressed genes in human bladder cancer cells using RNA fingerprinting. Epidermal Growth Factor (EGF) stimulation altered gene expression in J82 cells, revealing potential cancer biomarkers.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genomics

Background:

  • Human bladder cancer cell lines RT4 and J82 exhibit distinct growth responses to Epidermal Growth Factor (EGF).
  • Understanding gene expression changes is crucial for identifying molecular mechanisms in bladder cancer progression.

Purpose of the Study:

  • To detect differentially expressed genes in human bladder cancer cell lines.
  • To investigate the effect of EGF stimulation on gene expression profiles in RT4 and J82 cells.
  • To identify specific genes involved in EGF-mediated responses in bladder cancer.

Main Methods:

  • Utilized Arbitrarily Primed Polymerase Chain Reaction of RNA (RAP-PCR), a non-radioactive RNA fingerprinting technique.
  • Analyzed gene expression changes in EGF-stimulated RT4 and J82 bladder cancer cell lines.
  • Confirmed gene expression changes using reverse transcription PCR (RT-PCR).

Main Results:

  • RAP-PCR revealed altered gene expression patterns in EGF-treated J82 cells, but not in RT4 cells.
  • Sequencing of polymorphic fragments identified matches to human tropomyosin gene TM30(pl) and the human MAC30 gene.
  • Downregulation of specific genes in EGF-stimulated J82 cells was confirmed by RT-PCR.

Conclusions:

  • Arbitrarily Primed Polymerase Chain Reaction of RNA (RAP-PCR) is effective for detecting differential gene expression in cancer cell lines.
  • EGF stimulation influences gene expression in specific human bladder cancer cell lines (J82), potentially involving tropomyosin and MAC30 genes.
  • Identified genes warrant further investigation as potential diagnostic or therapeutic targets in bladder cancer.

Related Concept Videos